Tekmira Pharmaceuticals Corporation

Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira’s three lead RNAi product candidates target cholesterol management, cancer and Ebola infection.